Melanoma in Children, Adolescents, and Young Adults: A Clinical Pathological Study in a Brazilian Population
Carregando...
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
FRANCO, Dilcilea D. G. S.
SANGUEZA, Martin
Citação
AMERICAN JOURNAL OF DERMATOPATHOLOGY, v.36, n.8, p.620-628, 2014
Resumo
Malignant melanoma in children, adolescents, and young adults is unusual, especially before puberty. In children (age, 0-14 years), most primary lesions are thick and atypical (amelanotic, simulating pyogenic granuloma). In the population of adolescents and young adults (age, 15-39 years), melanoma is the third most common cancer, only behind lymphoma and breast cancer. Our study investigated the records of 89 patients diagnosed with cutaneous melanoma at age 0-39 years at Hospital das Cl nicas, Medical School, University of Sao Paulo between 1992 and 2002. They were divided into group A (0-14 years of age) and group B (15-39 years of age). The histopathology of all cases was reexamined. Statistical analysis of the data presented was performed, and the obtained data were compared with the literature. The frequency of melanoma in the group aged 15-39 years was higher in women, and the most affected site was the trunk. Additionally, melanomas were more frequent at an earlier age in patients with family history of melanoma (P = 0.014). Most cases were diagnosed, at histopathology, as superficial spreading melanoma. Thick nodular melanomas with Breslow values higher than 2 mm were associated with lymph node metastasis (P < 0.05). Our study revealed that melanoma in children, adolescents, and young adults may present peculiar behavior and outcome, which might reflect the genetic and yet not fully unraveled pathogenesis of this complex disease.
Palavras-chave
melanoma, children, adolescents, young adults
Referências
- Aldrink JH, 2009, J PEDIATR SURG, V44, P1514, DOI 10.1016/j.jpedsurg.2008.12.003
- Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799
- Bandarchi B, 2010, DERMATOL RES PRACT, V2010, P1, DOI [DOI 10.1155/2010/583748, 10.1155/2010/583748]
- Bataille V, 2013, MED HYPOTHESES, V81, P846, DOI 10.1016/j.mehy.2013.05.031
- Bataille V, 2004, EUR J CANCER, V40, P429, DOI 10.1016/j.ejca.2003.09.030
- Berk DR, 2010, PEDIATR DERMATOL, V27, P244, DOI 10.1111/j.1525-1470.2009.01078.x
- Bleyer A, 2006, NIH PUB, V06-5767
- Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609
- Bressac-de-Paillerets B, 2002, BIOCHIMIE, V84, P67, DOI 10.1016/S0300-9084(01)01360-8
- Busam KJ, 2009, AM J SURG PATHOL, V33, P1386, DOI 10.1097/PAS.0b013e3181ac1927
- Cadili A, 2010, CAN J SURG, V53, P32
- Cerroni L, 2010, AM J SURG PATHOL, V34, P314, DOI 10.1097/PAS.0b013e3181cf7fa0
- Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166
- Cordoro KM, 2013, J AM ACAD DERMATOL, V68, P913, DOI 10.1016/j.jaad.2012.12.953
- Daniotti M, 2009, J INVEST DERMATOL, V129, P1759, DOI 10.1038/jid.2008.422
- Durbec F, 2012, BRIT J DERMATOL, V166, P727, DOI 10.1111/j.1365-2133.2011.10772.x
- Ferrari A, 2005, PEDIATRICS, V115, P649, DOI 10.1542/peds.2004-0471
- Gamba CS, 2013, JAMA DERMATOL JUN, P1
- Gerami P, 2013, AM J SURG PATHOL, V37, P1387, DOI 10.1097/PAS.0b013e31828fc283
- Gosh P, 2009, EXPERT REV DERMATOL, V4, P131
- Gualandri L, 2009, J EUR ACAD DERMATOL, V23, P283, DOI 10.1111/j.1468-3083.2008.03041.x
- Han D, 2012, ANN SURG ONCOL, V19, P3888, DOI 10.1245/s10434-012-2554-5
- Jhappan C, 2003, ONCOGENE, V22, P3099, DOI 10.1038/sj.onc.1206450
- Kirkwood JM, 2009, SEMIN ONCOL, V36, P419, DOI 10.1053/j.seminoncol.2009.07.001
- Lambie M, 2011, ANN PLAS SURG, V67, P85, DOI 10.1097/SAP.0b013e3181e0fcbc
- Lewis KG, 2008, DERMATOL SURG, V34, P152, DOI 10.1111/j.1524-4725.2007.34032.x
- Lohmann CM, 2002, AM J SURG PATHOL, V26, P47, DOI 10.1097/00000478-200201000-00005
- Ludgate MW, 2009, CANCER, V115, P631, DOI 10.1002/cncr.24047
- Mark PP, 2008, J INVEST DERMATOL, V128, P2905
- Mones JM, 2003, AM J DERMATOPATH, V25, P223, DOI 10.1097/00000372-200306000-00007
- Neier M, 2012, J PEDIAT HEMATOL ONC, V34, pS51, DOI 10.1097/MPH.0b013e31824e3852
- Pappo AS, 2003, EUR J CANCER, V39, P2651, DOI 10.1016/j.ejca.2003.06.001
- Paradela S, 2011, ARCH PATHOL LAB MED, V135, P307, DOI 10.1043/2009-0503-RA.1
- Paradela S, 2010, CANCER-AM CANCER SOC, V116, P4334, DOI 10.1002/cncr.25222
- Raskin L, 2011, AM J SURG PATHOL, V35, P243, DOI 10.1097/PAS.0b013e31820393ee
- Rouhani Panta, 2008, Cancer Control, V15, P248
- Strouse JJ, 2005, J CLIN ONCOL, V23, P4735, DOI 10.1200/JCO.2005.02.899
- Su LD, 2003, CANCER, V97, P499, DOI 10.1002/cncr.11074
- Thomas JM, 2008, NAT CLIN PRACT ONCOL, V5, P18, DOI 10.1038/ncponc1014
- Tucker MA, 1997, JAMA-J AM MED ASSOC, V277, P1439, DOI 10.1001/jama.277.18.1439
- Weir HK, 2011, J AM ACAD DERMATOL, V65
- White RL, 2011, ANN SURG ONCOL, V18, P3593, DOI 10.1245/s10434-011-1826-9